ACE2 and myeloid sarcoma: Furthermore, in a study of MS patients with COVID-19, researchers found SARS-CoV-2 (as well as ACE2) within CP epithelial cells and ependymal cells of both MS and non-MS patients with no evidence of neuronal and glial infection [246].